194 related articles for article (PubMed ID: 33090392)
1. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
Yao FZ; He R; Jiang YC; Hou Y; Qian D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
[TBL] [Abstract][Full Text] [Related]
3. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
5. MiR-140-5p and miR-92a-3p suppress the cell proliferation, migration and invasion and promoted apoptosis in Wilms' tumor by targeting FRS2.
Li JL; Luo P
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):97-108. PubMed ID: 31957822
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MEG3 inhibits the growth, invasion and migration of Wilms' tumor via Wnt/β-catenin pathway.
Teng GY; Wang YJ; Geng M; Jiang ZP
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9899-9907. PubMed ID: 33090393
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
Zhu KR; Sun QF; Zhang YQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
Wang GF; Wen LN
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
[TBL] [Abstract][Full Text] [Related]
9. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
Shi XY; Lin JJ; Ge XJ; Shi Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
11. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
13. Silencing of lncRNA XIST suppresses proliferation and autophagy and enhances vincristine sensitivity in retinoblastoma cells by sponging miR-204-5p.
Yao L; Yang L; Song H; Liu TG; Yan H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3526-3537. PubMed ID: 32329826
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-203a-5p alleviates the malignant progression of Wilms' tumor via targeting JAG1.
Bao JW; Li WJ; Guo JH; Lv ZB; Whang Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5329-5335. PubMed ID: 32495866
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p/NEK5 axis in nasopharyngeal carcinoma.
Zhao CH; Bai XF; Hu XH
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2505-2517. PubMed ID: 32196601
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
[No Abstract] [Full Text] [Related]
17. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
18. The Long Non-Coding RNA XIST Controls Non-Small Cell Lung Cancer Proliferation and Invasion by Modulating miR-186-5p.
Wang H; Shen Q; Zhang X; Yang C; Cui S; Sun Y; Wang L; Fan X; Xu S
Cell Physiol Biochem; 2017; 41(6):2221-2229. PubMed ID: 28448993
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA XIST Promotes Wilms Tumor Progression Through the miR-194-5p/YAP Axis.
He X; Luo X; Dong J; Deng X; Liu F; Wei G
Cancer Manag Res; 2021; 13():3171-3180. PubMed ID: 33883934
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of Xist and Mir-7a-5p improves LPS-induced myocardial injury.
Liang D; Jin Y; Lin M; Xia X; Chen X; Huang A
Int J Med Sci; 2020; 17(16):2570-2577. PubMed ID: 33029099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
